temelimab

  1. SNT Gatchaman

    Trial Report Temelimab versus placebo in patients with post-COVID condition, 2026, Nehme et al.

    Temelimab versus placebo in patients with post-COVID condition INTRODUCTION More than 400 million individuals are estimated to have been affected by post-COVID condition or long COVID. This condition can lead to significantly decreased quality of life and increased individual and societal...
  2. J

    Temelimab

    Temelimab #3, l'évolution de mon état après 2 injections Translation: Temelimab #3, the evolution of my condition after 2 injections
Back
Top Bottom